Minerva Neurosciences
NERV
47 hedge funds and large institutions have $231M invested in Minerva Neurosciences in 2026 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 3 closing their positions.
500% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 3
114% more capital invested
Capital invested by funds: $108M → $231M (+$123M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
42% more funds holding
Funds holding: 33 → 47 (+14)
35.18% more ownership
Funds ownership: 53.32% → 88.5% (+35%)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$24.6M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$24.4M |
| 3 |
FCMV
Foresite Capital Management VI
Larkspur,
California
|
+$11.4M |
| 4 |
TECP
Trails Edge Capital Partners
Atlanta,
Georgia
|
+$8.14M |
| 5 |
DT
DV Trading
Chicago,
Illinois
|
+$5.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$8.14M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.48M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$551K |
| 4 |
Renaissance Technologies
New York
|
-$341K |
| 5 |
LPC
Lion Point Capital
New York
|
-$141K |
NERV Hedge Fund Activity: Q1 2026 in Review
47 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2026, worth a combined $231M — up 114% from $108M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new NERV positions and 3 closed out — a net gain of 15 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $24.6M. The largest seller was Adage Capital Partners, cutting an estimated $8.14M.
- 47 institutional investors held Minerva Neurosciences (NERV) as of Q1 2026, up from 33 in Q4 2025.
- Funds reported $231M of Minerva Neurosciences stock for Q1 2026, up 114% quarter-over-quarter.
- 18 funds opened new Minerva Neurosciences positions in Q1 2026 and 3 closed out, a net change of +15 holders.
- The largest Minerva Neurosciences buyer in Q1 2026 was Janus Henderson Group, an estimated $24.6M added.
- The largest Minerva Neurosciences seller in Q1 2026 was Adage Capital Partners, an estimated $8.14M sold.
Based on aggregated 13F filings for Q1 2026.